Clinical Trials Logo

Apophysitis clinical trials

View clinical trials related to Apophysitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT05220969 Completed - Clinical trials for Genetic Predisposition

Total Genotype Score, Growth, Maturation and Loading Exposure as Risk Factors for Injury in Elite Male Youth Football

Start date: December 1, 2019
Phase:
Study type: Observational

A total genotype risk score was generated based on the findings of previous research for non-contact injury, non-contact muscle injury, tendon injury, ligament injury, fracture injury and apophysitis injury. This score was then compared with the incidence of injury between those with high, medium and low risk scores for each injury. The influence of different rates of growth, stages of physical maturation and loading exposure were then also included in the risk model to see if any interaction effects could be observed between genetic risk score and susceptibility to injury in different categories of growth, maturation and loading exposure.

NCT ID: NCT05174182 Active, not recruiting - Clinical trials for Osgood-Schlatter Disease

A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter

SOGOOD
Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The most common growth-related injury is Osgood Schlatter, which affects up to 1 in 5 physically active adolescents. It can cause long-term pain and potential discontinuation of sports and physical activity, with sequela well into adulthood. No effective conservative treatments have been documented, and clinical practice is characterized by a wealth of conflicting advice and modalities. A novel treatment approach has shown promising results in a small single-cohort study. Therefore, this study aims to compare this novel treatment with usual care in 10-16-year-old adolescents with Osgood Schlatter. This single-center pragmatic, double-blinded, randomized, controlled superiority trial, will have a two-group parallel arm design. Participants will undergo 3 months of treatment, followed by 2 months of self-management with self-reported knee function (KOOS-child 'Sport/rec') at 5 months as the primary endpoint. This trial comparing a novel treatment with usual care for adolescents with Osgood Schlatter could result in an evidence-based treatment ready for implementation in clinical practice, benefitting patients outcomes and clinicians.

NCT ID: NCT03589001 Completed - Clinical trials for Osgood-Schlatter Disease

24 Month Follow-up of Patients With Osgood Schlatter (OSD)

Start date: July 10, 2018
Phase:
Study type: Observational

Osgood Schlatter is a common knee condition, affecting approximately 10% of adolescents. OSD is thought to be a growth related pain conditon, and thus resolve after maturation. Despite this, there a lack of prospective data investigating whether this is in fact the case.

NCT ID: NCT01826071 Recruiting - Sever's Disease Clinical Trials

Comparison of Three Treatments for Lower Extremity Apophysitis

Start date: October 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to compare three different treatments for these types of lower extremity apophysitis- Osgood-Schlatter syndrome (OSS), Sinding-Larsen and Johansson syndrome (SLJ), or Sever's disease. The investigators hypothesize that adolescents who perform a home exercise program (HEP) consisting of active elongation exercises will have decreased pain and earlier return to sports and activities as compared to those who perform a HEP that consists of static stretching exercises or those who use symptomatic treatment with ice, acetaminophen or NSAIDs and activity modification.